+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mumps Virus Vaccine Live Market - Global Forecast 2026-2032- Product Image
Mumps Virus Vaccine Live Market - Global Forecast 2026-2032- Product Image
Sale

Mumps Virus Vaccine Live Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6126890
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Mumps Virus Vaccine Live Market is projected to reach USD 857.01 Million in 2026. It is expected to continue growing at a CAGR of 7.36%, reaching USD 1.30 Billion by 2032.

Mumps Virus Vaccine Live: Executive Summary

Live attenuated mumps vaccines remain an important tool for preventing mumps and reducing complications associated with infection. Their public-health value depends on sustained immunization coverage, reliable cold-chain management, timely outbreak response, and confidence in routine vaccination. Market conditions are shaped less by product differentiation than by national schedules, procurement systems, regulatory requirements, epidemiological surveillance, and access to primary healthcare.

Public-Health Priorities Are Reshaping Vaccine Delivery

The landscape is being transformed by stronger emphasis on life-course immunization, measles-mumps-rubella program integration, and rapid restoration of routine services after disruptions. Health authorities are also placing greater weight on coverage equity, catch-up campaigns, adverse-event monitoring, and resilient supply chains. Urbanization, population mobility, changing school-entry requirements, and periodic outbreaks increase the need for interoperable immunization records and responsive local surveillance.

Artificial Intelligence Supports Surveillance and Operations

Artificial intelligence can strengthen mumps-vaccine programs by identifying coverage gaps, supporting outbreak signal detection, improving demand planning, and prioritizing outreach. It can also help reconcile immunization records and analyze cold-chain or logistics data. These applications require representative datasets, clinical and epidemiological validation, privacy safeguards, cybersecurity controls, and human oversight. AI should support-not replace-public-health judgment, laboratory confirmation, or established vaccine-safety processes.

Regional Insights Across Six Vaccine Environments

North America generally benefits from established immunization infrastructure, while maintaining attention to localized coverage gaps and outbreak containment. Latin America continues to depend on strong national programs, equitable access, and reliable procurement across diverse health systems. Europe emphasizes schedule harmonization, safety communication, and cross-border disease surveillance. The Middle East requires adaptable delivery models amid varying health-system capacity and population mobility. Africa’s priorities include financing, cold-chain expansion, workforce capacity, and integration with broader immunization services. Asia-Pacific combines highly capable national programs with substantial differences in access, geography, and delivery reliability, making targeted coverage improvement especially important.

Group-Level Priorities Differ Across Multilateral Blocs

ASEAN members face varied delivery capacity and cross-border mobility, favoring coordinated surveillance and practical regional procurement approaches. BRICS countries span highly diverse epidemiological and health-system contexts, increasing the value of shared technical learning and resilient manufacturing or supply arrangements. The European Union benefits from regulatory and surveillance coordination, while national implementation remains central. G7 members can advance evidence-based communication, safety monitoring, and innovation in delivery systems. GCC countries can leverage concentrated healthcare infrastructure while addressing migrant and mobile populations. NATO members benefit from preparedness coordination and continuity planning for immunization services during emergencies.

Country Insights Highlight Diverse Implementation Needs

Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, the United Kingdom, and the United States generally have mature immunization systems, making coverage equity, confidence, record interoperability, and outbreak response central priorities. Brazil, Mexico, India, China, and Russia operate across large and diverse populations, where regional access, procurement continuity, surveillance quality, and public communication are critical. Across all listed countries, national schedule alignment, school and community outreach, reliable cold-chain performance, and transparent safety reporting support sustained protection.

Actions for Leaders to Strengthen Vaccine Programs

Industry and public-health leaders should align product planning with national schedules and procurement requirements; invest in temperature-controlled logistics and contingency supply; and support interoperable digital immunization records. They should segment outreach toward under-immunized communities, partner with trusted healthcare professionals, and use clear evidence-based communication to address hesitancy. Organizations should also maintain rigorous pharmacovigilance, validate AI-assisted tools before deployment, and establish measurable indicators for coverage, timeliness, stock availability, and outbreak response.

Research Methodology for the Executive Summary

This summary applies a qualitative, evidence-oriented framework to the live mumps vaccine landscape. It considers immunization policy, epidemiology, delivery infrastructure, procurement, regulation, surveillance, cold-chain requirements, digital health, and regional implementation conditions. Insights are organized across the specified regions, country groupings, and countries. No market estimates, market sizing, market shares, forecasts, or company-specific assessments are included; conclusions are limited to structural and operational implications supported by established public-health principles.

Conclusion: Resilience and Coverage Remain Central

The live mumps vaccine landscape is principally shaped by the effectiveness and resilience of immunization systems. Sustained routine coverage, equitable access, dependable supply, trusted safety communication, and rapid surveillance-led response will determine program performance across diverse geographies. Leaders that combine operational discipline with responsible digital innovation can strengthen protection while improving readiness for future outbreaks and service disruptions.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Mumps Virus Vaccine Live Market, by Vaccine Type
7.1. Introduction
7.2. Combination Vaccine
7.2.1. Mmr Vaccine
7.2.2. MmrV Vaccine
7.3. Monovalent Vaccine
8. Mumps Virus Vaccine Live Market, by Age Group
8.1. Introduction
8.2. Adolescent
8.3. Adult
8.4. Pediatric
9. Mumps Virus Vaccine Live Market, by Technology
9.1. Introduction
9.2. Dna Vaccine
9.3. Live Attenuated Vaccine
9.4. Recombinant Vaccine
10. Mumps Virus Vaccine Live Market, by Route Of Administration
10.1. Introduction
10.2. Intramuscular
10.3. Subcutaneous
11. Mumps Virus Vaccine Live Market, by Dose Type
11.1. Introduction
11.2. Multi Dose
11.3. Single Dose
12. Mumps Virus Vaccine Live Market, by Formulation
12.1. Introduction
12.2. Liquid Solution
12.3. Lyophilized Powder
13. Mumps Virus Vaccine Live Market, by Distribution Channel
13.1. Introduction
13.2. Clinic
13.2.1. Community Clinic
13.2.2. Specialty Clinic
13.3. Hospital Pharmacy
13.3.1. Private Hospital
13.3.2. Public Hospital
13.4. Online Pharmacy
13.4.1. Direct To Consumer Pharmacy
13.4.2. Third Party Marketplace
13.5. Retail Pharmacy
13.5.1. Chain Pharmacy
13.5.2. Independent Pharmacy
14. Mumps Virus Vaccine Live Market, by Region
14.1. Introduction
14.2. Asia-Pacific
14.3. North America
14.4. Latin America
14.5. Europe
14.6. Middle East
14.7. Africa
15. Mumps Virus Vaccine Live Market, by Group
15.1. Introduction
15.2. ASEAN
15.3. GCC
15.4. European Union
15.5. BRICS
15.6. G7
15.7. NATO
16. Mumps Virus Vaccine Live Market, by Country
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. United Kingdom
16.7. Germany
16.8. France
16.9. Russia
16.10. Italy
16.11. Spain
16.12. China
16.13. India
16.14. Japan
16.15. Australia
16.16. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
17.2.1. Concentration Ratio (CR)
17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025
18. Company Profiles
18.1. AstraZeneca
18.2. Bavarian Nordic
18.3. Bharat Biotech International Limited
18.4. Biological E. Limited
18.5. CSL Limited
18.6. GSK plc
18.7. Hualan Biological Engineering Inc.
18.8. Johnson & Johnson
18.9. Merck & Co., Inc.
18.10. Pfizer Inc.
18.11. Sanofi
18.12. Serum Institute of India Pvt. Ltd.
18.13. Sinovac Biotech Ltd.
18.14. Takeda Pharmaceutical Company Limited
18.15. Zydus Lifesciences Limited
19. Key Experts
LIST OF FIGURES
FIGURE 1. Global Mumps Virus Vaccine Live Market, Years Considered for the Study
FIGURE 2. Global Mumps Virus Vaccine Live Market, Research Design
FIGURE 3. Global Mumps Virus Vaccine Live Market, Research Framework
FIGURE 4. Global Mumps Virus Vaccine Live Market, Data Triangulation
FIGURE 5. Global Mumps Virus Vaccine Live Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2025 vs 2032 (%)
FIGURE 7. Global Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Mumps Virus Vaccine Live Market Size, by Age Group, 2025 vs 2032 (%)
FIGURE 9. Global Mumps Virus Vaccine Live Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Mumps Virus Vaccine Live Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 11. Global Mumps Virus Vaccine Live Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 13. Global Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Mumps Virus Vaccine Live Market Size, by Dose Type, 2025 vs 2032 (%)
FIGURE 15. Global Mumps Virus Vaccine Live Market Size, by Dose Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Mumps Virus Vaccine Live Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 17. Global Mumps Virus Vaccine Live Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 19. Global Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Mumps Virus Vaccine Live Market Size, by Region, 2025 vs 2032 (%)
FIGURE 21. Global Mumps Virus Vaccine Live Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Mumps Virus Vaccine Live Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Mumps Virus Vaccine Live Market Size, by Country, 2025 vs 2032 (%)
FIGURE 24. Global Mumps Virus Vaccine Live Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Mumps Virus Vaccine Live Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Mumps Virus Vaccine Live Market Segmentation & Coverage
TABLE 2. Global Mumps Virus Vaccine Live Market Size, 2017-2032 (USD Million)
TABLE 3. Global Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 4. Global Combination Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Combination Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Combination Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Mmr Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Mmr Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Mmr Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global MmrV Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global MmrV Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global MmrV Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Monovalent Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Monovalent Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Monovalent Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 17. Global Adolescent Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Adolescent Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Adolescent Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 27. Global Dna Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Dna Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Dna Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Live Attenuated Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Live Attenuated Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Live Attenuated Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Recombinant Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Recombinant Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Recombinant Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 37. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 44. Global Multi Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Multi Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Multi Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Single Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Single Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Single Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 51. Global Liquid Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Liquid Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Liquid Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Lyophilized Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Lyophilized Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Lyophilized Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 58. Global Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Community Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Community Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Community Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Specialty Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Specialty Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Specialty Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Private Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Private Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Private Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Public Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Public Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Public Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Direct To Consumer Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Direct To Consumer Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Direct To Consumer Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Third Party Marketplace Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Third Party Marketplace Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Third Party Marketplace Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Chain Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Chain Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Chain Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Independent Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Independent Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Independent Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Mumps Virus Vaccine Live Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Mumps Virus Vaccine Live Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 108. North America Mumps Virus Vaccine Live Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. North America Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 110. North America Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 111. North America Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 112. North America Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 113. North America Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 114. North America Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 115. North America Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 116. North America Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. North America Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 118. North America Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 119. North America Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 120. North America Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 121. Latin America Mumps Virus Vaccine Live Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Latin America Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 123. Latin America Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 124. Latin America Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 125. Latin America Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 126. Latin America Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 127. Latin America Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 128. Latin America Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 129. Latin America Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 130. Latin America Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 131. Latin America Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 132. Latin America Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 133. Latin America Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 134. Europe Mumps Virus Vaccine Live Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Europe Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 136. Europe Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 137. Europe Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 138. Europe Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 139. Europe Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 140. Europe Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 141. Europe Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 142. Europe Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 143. Europe Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 144. Europe Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 145. Europe Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 146. Europe Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 147. Middle East Mumps Virus Vaccine Live Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Middle East Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 149. Middle East Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 150. Middle East Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 151. Middle East Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 152. Middle East Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 153. Middle East Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 154. Middle East Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 155. Middle East Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 156. Middle East Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 157. Middle East Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 158. Middle East Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 159. Middle East Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 160. Africa Mumps Virus Vaccine Live Market Size, by Region, 2017-2032 (USD Million)
TABLE 161. Africa Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 162. Africa Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 163. Africa Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 164. Africa Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 165. Africa Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 166. Africa Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 167. Africa Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 168. Africa Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 169. Africa Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 170. Africa Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 171. Africa Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 172. Africa Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 173. Global Mumps Virus Vaccine Live Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. ASEAN Mumps Virus Vaccine Live Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. ASEAN Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 176. ASEAN Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 177. ASEAN Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 178. ASEAN Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 179. ASEAN Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 180. ASEAN Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 181. ASEAN Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 182. ASEAN Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 183. ASEAN Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 184. ASEAN Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 185. ASEAN Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 186. ASEAN Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 187. GCC Mumps Virus Vaccine Live Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. GCC Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 189. GCC Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 190. GCC Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 191. GCC Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 192. GCC Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 193. GCC Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 194. GCC Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 195. GCC Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. GCC Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 197. GCC Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 198. GCC Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 199. GCC Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 200. European Union Mumps Virus Vaccine Live Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. European Union Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 202. European Union Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 203. European Union Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 204. European Union Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 205. European Union Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 206. European Union Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 207. European Union Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 208. European Union Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 209. European Union Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 210. European Union Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 211. European Union Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 212. European Union Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 213. BRICS Mumps Virus Vaccine Live Market Size, by Group, 2017-2032 (USD Million)
TABLE 214. BRICS Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 215. BRICS Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 216. BRICS Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 217. BRICS Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 218. BRICS Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 219. BRICS Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 220. BRICS Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 221. BRICS Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 222. BRICS Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 223. BRICS Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 224. BRICS Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 225. BRICS Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 226. G7 Mumps Virus Vaccine Live Market Size, by Group, 2017-2032 (USD Million)
TABLE 227. G7 Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 228. G7 Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 229. G7 Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 230. G7 Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 231. G7 Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 232. G7 Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 233. G7 Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 234. G7 Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 235. G7 Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 236. G7 Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 237. G7 Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 238. G7 Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 239. NATO Mumps Virus Vaccine Live Market Size, by Group, 2017-2032 (USD Million)
TABLE 240. NATO Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 241. NATO Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 242. NATO Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 243. NATO Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 244. NATO Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 245. NATO Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 246. NATO Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 247. NATO Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 248. NATO Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 249. NATO Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 250. NATO Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 251. NATO Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 252. Global Mumps Virus Vaccine Live Market Size, by Country, 2017-2032 (USD Million)
TABLE 253. United States Mumps Virus Vaccine Live Market Size, 2017-2032 (USD Million)
TABLE 254. United States Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 255. United States Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 256. United States Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 257. United States Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 258. United States Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 259. United States Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 260. United States Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 261. United States Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 262. United States Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 263. United States Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 264. United States Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 265. United States Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 266. Canada Mumps Virus Vaccine Live Market Size, 2017-2032 (USD Million)
TABLE 267. Canada Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 268. Canada Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 269. Canada Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 270. Canada Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 271. Canada Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 272. Canada Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 273. Canada Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 274. Canada Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 275. Canada Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 276. Canada Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 277. Canada Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 278. Canada Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 279. Mexico Mumps Virus Vaccine Live Market Size, 2017-2032 (USD Million)
TABLE 280. Mexico Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 281. Mexico Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 282. Mexico Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 283. Mexico Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 284. Mexico Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 285. Mexico Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 286. Mexico Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 287. Mexico Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 288. Mexico Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 289. Mexico Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 290. Mexico Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 291. Mexico Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 292. Brazil Mumps Virus Vaccine Live Market Size, 2017-2032 (USD Million)
TABLE 293. Brazil Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 294. Brazil Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 295. Brazil Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 296. Brazil Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 297. Brazil Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 298. Brazil Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 299. Brazil Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 300. Brazil Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 301. Brazil Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 302. Brazil Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 303. Brazil Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 304. Brazil Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 305. United Kingdom Mumps Virus Vaccine Live Market Size, 2017-2032 (USD Million)
TABLE 306. United Kingdom Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 307. United Kingdom Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 308. United Kingdom Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 309. United Kingdom Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 310. United Kingdom Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 311. United Kingdom Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 312. United Kingdom Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 313. United Kingdom Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 314. United Kingdom Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 315. United Kingdom Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 316. United Kingdom Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 317. United Kingdom Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 318. Germany Mumps Virus Vaccine Live Market Size, 2017-2032 (USD Million)
TABLE 319. Germany Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 320. Germany Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 321. Germany Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 322. Germany Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 323. Germany Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 324. Germany Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 325. Germany Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 326. Germany Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 327. Germany Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 328. Germany Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 329. Germany Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 330. Germany Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 331. France Mumps Virus Vaccine Live Market Size, 2017-2032 (USD Million)
TABLE 332. France Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 333. France Mumps Virus Vaccine Live Market Size, by Combination Vaccine, 2017-2032 (USD Million)
TABLE 334. France Mumps Virus Vaccine Live Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 335. France Mumps Virus Vaccine Live Market Size, by Technology, 2017-2032 (USD Million)
TABLE 336. France Mumps Virus Vaccine Live Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 337. France Mumps Virus Vaccine Live Market Size, by Dose Type, 2017-2032 (USD Million)
TABLE 338. France Mumps Virus Vaccine Live Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 339. France Mumps Virus Vaccine Live Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 340. France Mumps Virus Vaccine Live Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 341. France Mumps Virus Vaccine Live Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 342. France Mumps Virus Vaccine Live Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 343. France Mumps Virus Vaccine Live Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 344. Russia Mumps Virus Vaccine Live Market Size, 2017-2032 (USD Million)
TABLE 345. Russia Mumps Virus Vaccine Live Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 346. Russia Mumps Virus

Companies Mentioned

  • AstraZeneca
  • Bavarian Nordic
  • Bharat Biotech International Limited
  • Biological E. Limited
  • CSL Limited
  • GSK plc
  • Hualan Biological Engineering Inc.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Takeda Pharmaceutical Company Limited
  • Zydus Lifesciences Limited

Related Topics

Related Reports

Preventive Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Preventive Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 195 Pages
  • Global
From
Mumps Vaccine (MumpsVax) Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Mumps Vaccine (MumpsVax) Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 250 Pages
  • Global
From
Measles, Mumps, Rubella, & Varicella Combined Vaccine Market - Global Forecast 2026-2032 - Product Image

Measles, Mumps, Rubella, & Varicella Combined Vaccine Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Respiratory Virus Vaccines Market - Global Strategic Business Report - Product Image

Respiratory Virus Vaccines Market - Global Strategic Business Report

  • Report
  • 474 Pages
  • Global
From
Pediatric Preventable Vaccine Market - Global Forecast 2026-2032 - Product Image

Pediatric Preventable Vaccine Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.